These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 1778877)

  • 21. Estimation of once-daily amikacin dose in critically ill adults.
    Šíma M; Hartinger J; Cikánková T; Slanař O
    J Chemother; 2018 Feb; 30(1):37-43. PubMed ID: 28950787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The volume limit in fluid resuscitation to prevent respiratory failure in massively burned children without inhalation injury.
    Okabayashi K; Ohtani M; Yamanoue T; Sera A; Wada S; Inoue T; Iwasaki Y
    Hiroshima J Med Sci; 2001 Jun; 50(2):41-5. PubMed ID: 11480460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Objective audiologic assessment of children treated with amikacin].
    Katona G; Czinner A
    Orv Hetil; 1999 Jun; 140(23):1305-7. PubMed ID: 10412266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of three dosage regimens of amikacin using pharmacokinetic models in patients with cystic fibrosis].
    Halacová M; Průsa R; Kotaska K; Vávrová V
    Cas Lek Cesk; 2004; 143(3):187-90. PubMed ID: 15134039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacokinetics of amikacin in infants and children].
    Takimoto M; Yano K; Fujita K; Yoshioka H; Sanae N; Maruyama S
    Jpn J Antibiot; 1987 Jun; 40(6):1125-8. PubMed ID: 3669294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Pharmacokinetics of Amikacin in Pediatric Patients: A Comprehensive Review of Population Pharmacokinetic Analyses.
    Illamola SM; Sherwin CM; van Hasselt JGC
    Clin Pharmacokinet; 2018 Oct; 57(10):1217-1228. PubMed ID: 29572662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Administration of higher doses of amikacin in early stages of sepsis in critically ill patients.
    Najmeddin F; Ahmadi A; Mahmoudi L; Sadeghi K; Khalili H; Ahmadvand A; Najafi A; Mojtahedzadeh M
    Acta Med Iran; 2014; 52(9):703-9. PubMed ID: 25325208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Individualization of the amikacin administration regimen on the basis of the relationship between its pharmacokinetics and the patient's status].
    Firsov AA; Nasonov VN; Murav'eva SA; Portnoĭ IuA; Savitskaia KI
    Antibiot Khimioter; 1990 Sep; 35(9):47-51. PubMed ID: 2275595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic drug monitoring of amikacin in preterm and term infants.
    Siddiqi A; Khan DA; Khan FA; Razzaq A
    Singapore Med J; 2009 May; 50(5):486-9. PubMed ID: 19495517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimizing the initial amikacin dosage in adults.
    White BP; Lomaestro B; Pai MP
    Antimicrob Agents Chemother; 2015 Nov; 59(11):7094-6. PubMed ID: 26282426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population pharmacokinetic parameters for Bayesian monitoring of amikacin therapy in intensive care unit patients.
    Debord J; Voultoury JC; Lachatre G; Gay C; Favereau JP; Gay R
    Eur J Clin Pharmacol; 1992; 43(4):435-6. PubMed ID: 1451727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous Antibiotic and Antifungal Agent Pharmacokinetic-Pharmacodynamic Dosing in Adults with Severe Burn Injury.
    Cota JM; FakhriRavari A; Rowan MP; Chung KK; Murray CK; Akers KS
    Clin Ther; 2016 Sep; 38(9):2016-31. PubMed ID: 27586127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of a Bayesian method of amikacin dosing in intensive care unit patients with normal or impaired renal function.
    Lacarelle B; Granthil C; Manelli JC; Bruder N; Francois G; Cano JP
    Ther Drug Monit; 1987 Jun; 9(2):154-60. PubMed ID: 3617153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of Renal Replacement Modalities on Amikacin Population Pharmacokinetics in Critically Ill Patients on Continuous Renal Replacement Therapy.
    Roger C; Wallis SC; Muller L; Saissi G; Lipman J; Lefrant JY; Roberts JA
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4901-9. PubMed ID: 27270279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple-dose amikacin kinetics in pediatric oncology patients.
    Kramer WG; Cleary T; Frankel LS; Kohl S; Pickering LK
    Clin Pharmacol Ther; 1979 Nov; 26(5):635-40. PubMed ID: 498705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amikacin pharmacokinetics in patients receiving high-dose cancer chemotherapy.
    Davis RL; Lehmann D; Stidley CA; Neidhart J
    Antimicrob Agents Chemother; 1991 May; 35(5):944-7. PubMed ID: 1854175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [In vivo pharmacokinetic of amikacin and its pharmacodynamic in combination with cefepime, cefpirome and meropenem in an in vitro/ex vivo micropig model].
    Elkhaïli H; Pompei D; Peter JD; Linger L; Salmon J; Levêque D; Niedergang S; Salmon Y; Thierry RC; Monteil H; Jehl F
    Pathol Biol (Paris); 1997 May; 45(5):347-56. PubMed ID: 9296083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Studies on the intravenous administration of amikacin to neonates].
    Masumi R; Hirama Y; Narita A; Nakazawa S; Iwasaki A; Niino K; Sato H; Nakazawa S; Tazoe K; Chikaoka H
    Jpn J Antibiot; 1987 Jun; 40(6):1146-56. PubMed ID: 3669297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A physiologic approach to fluid therapy in severely burned children.
    Carvajal HF
    Surg Gynecol Obstet; 1980 Mar; 150(3):379-84. PubMed ID: 7355364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Assessment of pharmacokinetic parameters of amikacin in a group of neutropenic patients in onco-hematology].
    Pivot-Dumarest C; Deweerdt C; Troncy J; Sorensen P; Roux D; Maire P
    Pathol Biol (Paris); 1996 Apr; 44(4):299-305. PubMed ID: 8763595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.